Cargando…
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome
Immunoproteasome inhibition is a promising strategy for the treatment of hematological malignancies, autoimmune diseases, and inflammatory diseases. The design of non-covalent inhibitors of the immunoproteasome β1i/β5i catalytic subunits could be a novel approach to avoid the drawbacks of the known...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341482/ https://www.ncbi.nlm.nih.gov/pubmed/37445688 http://dx.doi.org/10.3390/ijms241310504 |